Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by EVELYNE M LOYER and HARMEET KAUR.
EVELYNE M LOYER
Connection Strength
0.906
HARMEET KAUR
  1. Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management. AJR Am J Roentgenol. 2013 Oct; 201(4):W582-9.
    View in: PubMed
    Score: 0.116
  2. CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with bevacizumab. AJR Am J Roentgenol. 2011 Dec; 197(6):W1060-6.
    View in: PubMed
    Score: 0.102
  3. Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases. Am J Surg Pathol. 2010 Sep; 34(9):1287-94.
    View in: PubMed
    Score: 0.093
  4. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA. 2009 Dec 02; 302(21):2338-44.
    View in: PubMed
    Score: 0.089
  5. Radiologic findings in taxane induced colitis. Eur J Radiol. 2008 Apr; 66(1):75-8.
    View in: PubMed
    Score: 0.075
  6. Comparison of virtual to true unenhanced abdominal computed tomography images acquired using rapid kV-switching dual energy imaging. PLoS One. 2020; 15(9):e0238582.
    View in: PubMed
    Score: 0.047
  7. Tumors of the liver, bile duct, and pancreas. Curr Probl Diagn Radiol. 2000 May-Jun; 29(3):69-107.
    View in: PubMed
    Score: 0.046
  8. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma. Radiother Oncol. 2019 04; 133:54-61.
    View in: PubMed
    Score: 0.042
  9. Patterns of uterine enhancement with helical CT. Eur J Radiol. 1998 Oct; 28(3):250-5.
    View in: PubMed
    Score: 0.041
  10. Evaluating the Clinical Applicability of the European Staging System for Perihilar Cholangiocarcinoma. J Gastrointest Surg. 2016 Apr; 20(4):741-7.
    View in: PubMed
    Score: 0.034
  11. Importance of dynamic assessment of the soft tissues in the sonographic diagnosis of echogenic superficial abscesses. J Ultrasound Med. 1995 Sep; 14(9):669-71.
    View in: PubMed
    Score: 0.033
  12. RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases. Ann Surg Oncol. 2015 Mar; 22(3):834-842.
    View in: PubMed
    Score: 0.031
  13. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog. 2013 Nov; 52 Suppl 1:E139-47.
    View in: PubMed
    Score: 0.028
  14. SSAT/AHPBA joint symposium on evaluation and treatment of benign liver lesions. J Gastrointest Surg. 2013 Apr; 17(4):636-44.
    View in: PubMed
    Score: 0.028
  15. Case 177: Congenital absence of the portal vein with hepatic adenomatosis. Radiology. 2012 Jan; 262(1):364-7.
    View in: PubMed
    Score: 0.026
  16. Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis. Gastrointest Cancer Res. 2011 Sep; 4(5-6):155-60.
    View in: PubMed
    Score: 0.025
  17. Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation. Br J Surg. 2011 Jul; 98(7):1003-9.
    View in: PubMed
    Score: 0.024
  18. Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol. 2004 Mar; 182(3):619-23.
    View in: PubMed
    Score: 0.015
  19. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics. 2001 Oct; 21 Spec No:S41-54.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.